Exact Sciences stock heads into the open after a weaker Nasdaq close
Published on 09/11/2026 at 04:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Exact Sciences stock closed lower on the Nasdaq on September 10, 2026, with the shares ending the session down in percent terms and under pressure alongside the broader market. The move came as major United States equity indexes declined, leaving Exact Sciences stock aligned with a risk-off tone into today's session.
September 10, 2026 in numbers
Exact Sciences Inc. (ISIN US30063P1057, Nasdaq) finished trading on the Nasdaq on September 10, 2026 with a negative daily percent change compared with the previous session's close, reflecting selling interest through the afternoon. The stock's close sat within the intraday range between its day low and day high, and trading volume for the session exceeded a quieter earlier-week pattern, indicating more active positioning ahead of today's trade. In the same session, the S&P 500 fell 44.66 points, or 0.6%, to 7,591.70, according to Las Vegas Sun, underscoring that Exact Sciences moved in a broadly weaker market environment rather than against the trend.
Sector sentiment also played a role. As Zacks reported for the September 10, 2026 session, United States stocks broadly declined as investors reacted to higher oil prices and reassessed risk across growth and healthcare names, a backdrop that weighed on shares such as Exact Sciences. With the stock's daily loss comparing to a smaller percentage move in the S&P 500, the individual decline outpaced the benchmark's drop for the day.
Today's factors for Exact Sciences
Today, September 11, 2026, Exact Sciences heads into the open without a scheduled earnings release, but sentiment around the name remains tied to news flow in diagnostics and biotechnology peers as well as the broader macro calendar. According to the market wrap from Zacks, investors continue to watch energy prices and their impact on risk appetite across growth sectors, a factor that can influence trading in Exact Sciences today. In addition, upcoming economic data in the next few sessions, including United States releases cited by Zacks, may shape expectations for interest rates and valuations in healthcare, potentially affecting how Exact Sciences trades as investors adjust portfolios ahead of and after the open.
